CME Group Inc. (NASDAQ:CME) Shares Sold by Creative Planning

Creative Planning cut its position in CME Group Inc. (NASDAQ:CME) by 2.9% in the 2nd quarter, Holdings Channel.com reports. The firm owned 46,901 shares of the financial services provider’s stock after selling 1,411 shares during the quarter. Creative Planning’s holdings in CME Group were worth $9,221,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in CME. Salomon & Ludwin LLC acquired a new stake in shares of CME Group during the first quarter valued at about $28,000. Y.D. More Investments Ltd purchased a new position in CME Group in the second quarter valued at about $36,000. Rise Advisors LLC acquired a new stake in CME Group during the 1st quarter valued at approximately $41,000. McClarren Financial Advisors Inc. increased its holdings in CME Group by 66.1% during the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock worth $39,000 after purchasing an additional 78 shares during the last quarter. Finally, Asset Dedication LLC raised its position in shares of CME Group by 515.2% in the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock valued at $40,000 after purchasing an additional 170 shares in the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the transaction, the chief financial officer now directly owns 13,261 shares in the company, valued at approximately $2,877,504.39. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by insiders.

CME Group Stock Performance

Shares of CME opened at $225.28 on Wednesday. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $225.32. The firm has a fifty day moving average of $210.67 and a 200-day moving average of $207.48. The company has a market cap of $81.12 billion, a price-to-earnings ratio of 25.63, a price-to-earnings-growth ratio of 8.74 and a beta of 0.55.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, topping the consensus estimate of $2.53 by $0.03. The firm had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.53 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. CME Group’s quarterly revenue was up 12.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.30 EPS. As a group, equities analysts anticipate that CME Group Inc. will post 9.94 earnings per share for the current year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were paid a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a yield of 2.04%. The ex-dividend date was Monday, September 9th. CME Group’s payout ratio is currently 52.33%.

Analysts Set New Price Targets

CME has been the subject of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft raised their price target on shares of CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a research report on Thursday, August 15th. Piper Sandler reissued an “overweight” rating and issued a $225.00 target price on shares of CME Group in a research report on Tuesday, August 20th. Keefe, Bruyette & Woods increased their price target on shares of CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a research report on Thursday, July 25th. TD Cowen started coverage on CME Group in a report on Thursday, September 26th. They issued a “hold” rating and a $221.00 price objective for the company. Finally, Bank of America downgraded CME Group from a “neutral” rating to an “underperform” rating and reduced their target price for the stock from $212.00 to $177.00 in a report on Tuesday, September 3rd. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $212.54.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.